These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34545149)

  • 21. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
    Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
    Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.
    Drabarek W; Yavuzyigitoglu S; Obulkasim A; van Riet J; Smit KN; van Poppelen NM; Vaarwater J; Brands T; Eussen B; Verdijk RM; Naus NC; Mensink HW; Paridaens D; Boersma E; van de Werken HJG; Kilic E; de Klein A;
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3595-3605. PubMed ID: 31425584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular profiling of primary uveal melanoma: results of a Polish cohort.
    Kowalik A; Karpinski P; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P; Hoang MP
    Melanoma Res; 2023 Apr; 33(2):104-115. PubMed ID: 36719926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
    Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
    Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.
    Dono M; Angelini G; Cecconi M; Amaro A; Esposito AI; Mirisola V; Maric I; Lanza F; Nasciuti F; Viaggi S; Gualco M; Bandelloni R; Truini M; Coviello DA; Zupo S; Mosci C; Pfeffer U
    Br J Cancer; 2014 Feb; 110(4):1058-65. PubMed ID: 24423917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
    Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
    JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.
    Boru G; Cebulla CM; Sample KM; Massengill JB; Davidorf FH; Abdel-Rahman MH
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2474-2480. PubMed ID: 31173078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
    Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
    PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-derived xenografts recapitulate molecular features of human uveal melanomas.
    Laurent C; Gentien D; Piperno-Neumann S; Némati F; Nicolas A; Tesson B; Desjardins L; Mariani P; Rapinat A; Sastre-Garau X; Couturier J; Hupé P; de Koning L; Dubois T; Roman-Roman S; Stern MH; Barillot E; Harbour JW; Saule S; Decaudin D
    Mol Oncol; 2013 Jun; 7(3):625-36. PubMed ID: 23478236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
    Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uveal melanoma: physiopathology and new in situ-specific therapies.
    Souto EB; Zielinska A; Luis M; Carbone C; Martins-Gomes C; Souto SB; Silva AM
    Cancer Chemother Pharmacol; 2019 Jul; 84(1):15-32. PubMed ID: 31079217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.
    Field MG; Decatur CL; Kurtenbach S; Gezgin G; van der Velden PA; Jager MJ; Kozak KN; Harbour JW
    Clin Cancer Res; 2016 Mar; 22(5):1234-42. PubMed ID: 26933176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Spliceosome Inhibition in SF3B1-Mutated Uveal Melanoma.
    Nguyen JQN; Drabarek W; Leeflang AMCHJ; Brands T; van den Bosch TPP; Verdijk RM; van de Werken HJG; van Riet J; Paridaens D; de Klein A; Brosens E; Kiliç E;
    Invest Ophthalmol Vis Sci; 2024 Oct; 65(12):11. PubMed ID: 39374010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival.
    Abdel-Rahman MH; Cebulla CM; Verma V; Christopher BN; Carson WE; Olencki T; Davidorf FH
    Exp Eye Res; 2012 Jul; 100():26-31. PubMed ID: 22569040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
    Robertson AG; Shih J; Yau C; Gibb EA; Oba J; Mungall KL; Hess JM; Uzunangelov V; Walter V; Danilova L; Lichtenberg TM; Kucherlapati M; Kimes PK; Tang M; Penson A; Babur O; Akbani R; Bristow CA; Hoadley KA; Iype L; Chang MT; ; Cherniack AD; Benz C; Mills GB; Verhaak RGW; Griewank KG; Felau I; Zenklusen JC; Gershenwald JE; Schoenfield L; Lazar AJ; Abdel-Rahman MH; Roman-Roman S; Stern MH; Cebulla CM; Williams MD; Jager MJ; Coupland SE; Esmaeli B; Kandoth C; Woodman SE
    Cancer Cell; 2017 Aug; 32(2):204-220.e15. PubMed ID: 28810145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.
    Xu X; Wei WB; Li B; Gao F; Zhang Z; Jonas JB
    PLoS One; 2014; 9(10):e109699. PubMed ID: 25280020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
    Yu L; Zhou D; Zhang G; Ren Z; Luo X; Liu P; Plouffe SW; Meng Z; Moroishi T; Li Y; Zhang Y; Brown JH; Liu S; Guan KL
    Mol Oncol; 2022 Feb; 16(3):607-629. PubMed ID: 34706158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New concepts in the molecular understanding of uveal melanoma.
    Reichstein D
    Curr Opin Ophthalmol; 2017 May; 28(3):219-227. PubMed ID: 28257297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uveal Melanoma:
    Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
    Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
    Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
    Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.